19389237

Source:http://linkedlifedata.com/resource/pubmed/id/19389237

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0039099, umls-concept:C0087111, umls-concept:C0332197, umls-concept:C0681890, umls-concept:C0752248, umls-concept:C0871261, umls-concept:C1122087, umls-concept:C1519316, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	2
pubmed:dateCreated	2009-5-28
pubmed:abstractText	To identify markers and mechanisms of resistance to adalimumab therapy, we studied global gene expression profiles in synovial tissue specimens obtained from severe rheumatoid arthritis (RA) patients before and after initiation of treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-10643698, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-11083259, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-11406520, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-11508446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-11592367, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-12011369, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-12074593, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-12528101, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-12905468, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-14962934, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-15641091, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-15987488, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-16385498, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-16817978, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-17134501, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-17329305, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-17469140, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-18042642, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-18055470, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-18388148, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-18660510, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-7934491, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-8546736, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-8670314, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-8670315, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-9751087, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-9811053, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389237-9920948
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101154438
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/adalimumab
pubmed:status	MEDLINE
pubmed:issn	1478-6362
pubmed:author	pubmed-author:BadotValérieV, pubmed-author:DurezPatrickP, pubmed-author:GalantChristineC, pubmed-author:HoussiauFrédéric AFA, pubmed-author:LauwerysBernard RBR, pubmed-author:MaudouxAnne-LiseAL, pubmed-author:Nzeusseu ToukapAdrienA, pubmed-author:TheateIvanI, pubmed-author:Van den EyndeBenoît JBJ
pubmed:issnType	Electronic
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R57
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19389237-Adolescent, pubmed-meshheading:19389237-Adult, pubmed-meshheading:19389237-Aged, pubmed-meshheading:19389237-Aged, 80 and over, pubmed-meshheading:19389237-Antibodies, Monoclonal, pubmed-meshheading:19389237-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19389237-Antirheumatic Agents, pubmed-meshheading:19389237-Arthritis, Rheumatoid, pubmed-meshheading:19389237-Drug Resistance, pubmed-meshheading:19389237-Female, pubmed-meshheading:19389237-Gene Expression Profiling, pubmed-meshheading:19389237-Humans, pubmed-meshheading:19389237-Immunohistochemistry, pubmed-meshheading:19389237-Male, pubmed-meshheading:19389237-Middle Aged, pubmed-meshheading:19389237-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:19389237-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19389237-Synovial Membrane, pubmed-meshheading:19389237-Young Adult
pubmed:year	2009
pubmed:articleTitle	Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
pubmed:affiliation	Rheumatology Department, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. Valerie.Badot@chu-brugmann.be
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't